Professor van Cutsem discusses the importance of molecular markers in clinical practice, what factors are important in deciding the best treatment for colon cancer and how best to individualise and personalise cancer treatment.

The first Europacolon patients meeting in Lisbon is discussed. This will be the first time bowel cancer patients have had the opportunity to gather and talk about a number of aspects key to this cancer.

Watch Prof van Cutsem present data from the ToGA trial at the ASCO 2009 press conference.
Prof van Cutsem presents updates on the CRYSTAL study at the ESMO 33 press conference.
Prof van Cutsem speaks to ecancertv at ASCO 2009 about research into the treatment of colorectal cancer.